Gorevic Jason N's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Jul 28, 2023
- Accession no.
- 0001477449-23-000016
- Filed
- Jul 28, 2023
- Trade date
- Jul 27, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $300.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorevic Jason NCIK 0001208500 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2023 | Common Stock | SSaleDisposed | −10,000 | $30.03F2 | −$300,300 | 596,246 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of transactions ranging from $30.00 to $30.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Referenced by the price of 1 transaction in Table I.